Advus Financial Partners, LLC’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$506K Sell
3,936
-15
-0.4% -$1.76K 0.11% 128
2026
Q1
$475K Buy
3,951
+135
+4% +$15.6K 0.12% 127
2025
Q4
$402K Buy
3,816
+127
+3% +$11.9K 0.1% 149
2025
Q3
$310K Sell
3,689
-188
-5% -$15.5K 0.07% 194
2025
Q2
$307K Sell
3,877
-679
-15% -$54K 0.08% 188
2025
Q1
$409K Sell
4,556
-1,064
-19% -$99.3K 0.11% 126
2024
Q4
$559K Sell
5,620
-69
-1% -$7.11K 0.16% 96
2024
Q3
$646K Sell
5,689
-555
-9% -$65.9K 0.18% 81
2024
Q2
$773K Sell
6,244
-12
-0.2% -$1.55K 0.24% 63
2024
Q1
$825K Buy
6,256
+78
+1% +$9.61K 0.26% 59
2023
Q4
$674K Buy
6,178
+175
+3% +$18.2K 0.23% 63
2023
Q3
$618K Sell
6,003
-782
-12% -$84.3K 0.24% 62
2023
Q2
$783K Buy
6,785
+1,042
+18% +$118K 0.3% 51
2023
Q1
$611K Buy
5,743
+562
+11% +$60.7K 0.25% 57
2022
Q4
$575K Buy
5,181
+396
+8% +$40.5K 0.25% 56
2022
Q3
$412K Buy
4,785
+850
+22% +$75.9K 0.22% 71
2022
Q2
$359K Buy
3,935
+1,182
+43% +$105K 0.19% 75
2022
Q1
$226K Buy
+2,753
New +$217K 0.12% 111

Other funds holding MRK

Advus Financial Partners, LLC's MRK Position: Q2 2026 in Review

Advus Financial Partners, LLC reduced its Merck (MRK) stake by 0.38% in Q2 2026, selling an estimated $1.76K and leaving 3,936 shares worth $506K. The position accounts for 0.11% of the portfolio, ranked #128.

Advus Financial Partners, LLC first reported a position in MRK in Q1 2022 and has held it in 18 quarters since. The position peaked at $825K in Q1 2024. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Advus Financial Partners, LLC held 3,936 shares of Merck worth $506K as of Q2 2026.
  • Advus Financial Partners, LLC sold 15 Merck shares in Q2 2026, an estimated $1.76K.
  • Merck made up 0.11% of Advus Financial Partners, LLC's portfolio in Q2 2026, its #128 holding.
  • Advus Financial Partners, LLC first reported a position in Merck in Q1 2022 and has held it in 18 quarters since.
  • Advus Financial Partners, LLC's Merck position peaked at $825K in Q1 2024.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Advus Financial Partners, LLC's 13F filing for Q2 2026, filed 25 Aug 2026.